With more shares now under the control of its majority stockholder
, cement manufacturer Cemex Holdings Philippines Inc.
Eidos Therapeutics (EIDX) confirmed that it has received a non-binding proposal dated August 8 from BridgeBio Pharma (BBIO), the parent entity of the company's majority stockholder
, to purchase all of the outstanding common stock of the company not already owned by BridgeBio.
(Mayne) (publicly traded Australian company on ASX exchange), which, allegedly, is HPPI's majority stockholder
and a wholly-owned indirect subsidiary of Mayne Pharma Group Limited.
Having previously received the requisite regulatory non-objection, the company's majority stockholder
, NorthEast Community Bancorp, MHC, had decided to waive receipt of the quarterly dividend.
chairman and managing partner of Accelmed (Strata's majority stockholder
), undertook a campaign of false, misleading, and disparaging statements to Ra Medical's financial partners and potential investors before, during, and after Ra Medical's initial public offering.
Vinson and Elkins LLP is acting as legal advisor to EnCap Investments, the majority stockholder
of Eclipse Resources.
The company said it will reestablish the Kia brand in the Philippines, by forming a joint venture company, with AC Industrials as majority stockholder
, with Columbian Autocar Corp., Kia's former distributor in the country.
Jim McClure is president and majority stockholder
of Drysdales.<br />With the two Drysdales stores, Boot Barn operates 232 stores in 31 states.
Under the repurchase program, repurchases can be made from time to time using a variety of methods, which may include open market purchases, privately negotiated transactions or otherwise (but will not include purchases of common stock by the company from Deutsche Telekom AG, our majority stockholder
), all in accordance with the rules of the Securities and Exchange Commission and other applicable legal requirements.
Travel Service, which already owned a 34% stake in Czech Airlines, will become the majority stockholder
by raising its stake to 97.74%.
The majority stockholder
of Taminco has agreed, subject to certain conditions, including the Taminco Board's continuing recommendation of the transaction, to vote its shares of Taminco's common stock in favor of the acquisition.
It was reported on Tuesday that the patent was granted to the company's parent and majority stockholder
, Can-Fite BioPharma Ltd, and relates to OphthaliX's drug candidate, CF101.